Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 56557 to 808 of 808 entries
Sorted by: Best Match Show Resources per page
Effect of Treatment of Clinical Seizures vs Electrographic Seizures in Full-Term and Near-Term Neonates: A Randomized Clinical Trial.

JAMA network open

Hunt RW, Liley HG, Wagh D, Schembri R, Lee KJ, Shearman AD, Francis-Pester S, deWaal K, Cheong JYL, Olischar M, Badawi N, Wong FY, Osborn DA, Rajadurai VS, Dargaville PA, Headley B, Wright I, Colditz PB.
PMID: 34919132
JAMA Netw Open. 2021 Dec 01;4(12):e2139604. doi: 10.1001/jamanetworkopen.2021.39604.

IMPORTANCE: Seizures in the neonatal period are associated with increased mortality and morbidity. Bedside amplitude-integrated electroencephalography (aEEG) has facilitated the detection of electrographic seizures; however, whether these seizures should be treated remains uncertain.OBJECTIVE: To determine if the active management...

Cite
Hunt RW, Liley HG, Wagh D, et al. Effect of Treatment of Clinical Seizures vs Electrographic Seizures in Full-Term and Near-Term Neonates: A Randomized Clinical Trial. JAMA Netw Open. 2021;4(12):e2139604doi: 10.1001/jamanetworkopen.2021.39604.
Hunt, R. W., Liley, H. G., Wagh, D., Schembri, R., Lee, K. J., Shearman, A. D., Francis-Pester, S., deWaal, K., Cheong, J. Y. L., Olischar, M., Badawi, N., Wong, F. Y., Osborn, D. A., Rajadurai, V. S., Dargaville, P. A., Headley, B., Wright, I., Colditz, P. B. (2021). Effect of Treatment of Clinical Seizures vs Electrographic Seizures in Full-Term and Near-Term Neonates: A Randomized Clinical Trial. JAMA network open, 4(12), e2139604. https://doi.org/10.1001/jamanetworkopen.2021.39604
Hunt, Rod W, et al. "Effect of Treatment of Clinical Seizures vs Electrographic Seizures in Full-Term and Near-Term Neonates: A Randomized Clinical Trial." JAMA network open vol. 4,12 (2021): e2139604. doi: https://doi.org/10.1001/jamanetworkopen.2021.39604
Hunt RW, Liley HG, Wagh D, Schembri R, Lee KJ, Shearman AD, Francis-Pester S, deWaal K, Cheong JYL, Olischar M, Badawi N, Wong FY, Osborn DA, Rajadurai VS, Dargaville PA, Headley B, Wright I, Colditz PB. Effect of Treatment of Clinical Seizures vs Electrographic Seizures in Full-Term and Near-Term Neonates: A Randomized Clinical Trial. JAMA Netw Open. 2021 Dec 01;4(12):e2139604. doi: 10.1001/jamanetworkopen.2021.39604. PMID: 34919132.
Copy Download .nbib Format: NLM
Outpatient Treatment of Chronic Designer Benzodiazepine Use: A Case Report.

Journal of addiction medicine

Hauck TS, Rochon S, Bahra P, Selby P.
PMID: 33900229
J Addict Med. 2021 Apr 26; doi: 10.1097/ADM.0000000000000857. Epub 2021 Apr 26.

BACKGROUND: Novel psychoactive substances, such as designer benzodiazepines unapproved for therapeutic purposes, are an emerging concern worldwide. They have unknown or unpredictable pharmacological properties. Using a case example, we discuss the use of "Xanax bars," which now generally do...

Cite
Hauck TS, Rochon S, Bahra P, et al. Outpatient Treatment of Chronic Designer Benzodiazepine Use: A Case Report. J Addict Med. 2021;doi: 10.1097/ADM.0000000000000857.
Hauck, T. S., Rochon, S., Bahra, P., & Selby, P. (2021). Outpatient Treatment of Chronic Designer Benzodiazepine Use: A Case Report. Journal of addiction medicine, . https://doi.org/10.1097/ADM.0000000000000857
Hauck, Tanya S, et al. "Outpatient Treatment of Chronic Designer Benzodiazepine Use: A Case Report." Journal of addiction medicine vol. (2021). doi: https://doi.org/10.1097/ADM.0000000000000857
Hauck TS, Rochon S, Bahra P, Selby P. Outpatient Treatment of Chronic Designer Benzodiazepine Use: A Case Report. J Addict Med. 2021 Apr 26; doi: 10.1097/ADM.0000000000000857. Epub 2021 Apr 26. PMID: 33900229.
Copy Download .nbib Format: NLM
Anticonvulsants and Chromatin-Genes Expression: A Systems Biology Investigation.

Frontiers in neuroscience

Kowalski TW, Gomes JDA, Feira MF, Dupont ÁV, Recamonde-Mendoza M, Vianna FSL.
PMID: 33328862
Front Neurosci. 2020 Nov 25;14:591196. doi: 10.3389/fnins.2020.591196. eCollection 2020.

Embryofetal development is a critical process that needs a strict epigenetic control, however, perturbations in this balance might lead to the occurrence of congenital anomalies. It is known that anticonvulsants potentially affect epigenetics-related genes, however, it is not comprehended...

Cite
Kowalski TW, Gomes JDA, Feira MF, et al. Anticonvulsants and Chromatin-Genes Expression: A Systems Biology Investigation. Front Neurosci. 2020;14:591196doi: 10.3389/fnins.2020.591196.
Kowalski, T. W., Gomes, J. D. A., Feira, M. F., Dupont, �. �. V., Recamonde-Mendoza, M., & Vianna, F. S. L. (2020). Anticonvulsants and Chromatin-Genes Expression: A Systems Biology Investigation. Frontiers in neuroscience, 14591196. https://doi.org/10.3389/fnins.2020.591196
Kowalski, Thayne Woycinck, et al. "Anticonvulsants and Chromatin-Genes Expression: A Systems Biology Investigation." Frontiers in neuroscience vol. 14 (2020): 591196. doi: https://doi.org/10.3389/fnins.2020.591196
Kowalski TW, Gomes JDA, Feira MF, Dupont ÁV, Recamonde-Mendoza M, Vianna FSL. Anticonvulsants and Chromatin-Genes Expression: A Systems Biology Investigation. Front Neurosci. 2020 Nov 25;14:591196. doi: 10.3389/fnins.2020.591196. eCollection 2020. PMID: 33328862; PMCID: PMC7732676.
Copy Download .nbib Format: NLM
Identification of New Compounds with Anticonvulsant and Antinociceptive Properties in a Group of 3-substituted (2,5-dioxo-pyrrolidin-1-yl)(phenyl)-Acetamides.

International journal of molecular sciences

Abram M, Jakubiec M, Rapacz A, Mogilski S, Latacz G, Szulczyk B, Szafarz M, Socała K, Nieoczym D, Wyska E, Wlaź P, Kamiński RM, Kamiński K.
PMID: 34884898
Int J Mol Sci. 2021 Dec 03;22(23). doi: 10.3390/ijms222313092.

We report herein a series of water-soluble analogues of previously described anticonvulsants and their detailed in vivo and in vitro characterization. The majority of these compounds demonstrated broad-spectrum anticonvulsant properties in animal seizure models, including the maximal electroshock (MES)...

Cite
Abram M, Jakubiec M, Rapacz A, et al. Identification of New Compounds with Anticonvulsant and Antinociceptive Properties in a Group of 3-substituted (2,5-dioxo-pyrrolidin-1-yl)(phenyl)-Acetamides. Int J Mol Sci. 2021;22(23)doi: 10.3390/ijms222313092.
Abram, M., Jakubiec, M., Rapacz, A., Mogilski, S., Latacz, G., Szulczyk, B., Szafarz, M., Socała, K., Nieoczym, D., Wyska, E., Wlaź, P., Kamiński, R. M., & Kamiński, K. (2021). Identification of New Compounds with Anticonvulsant and Antinociceptive Properties in a Group of 3-substituted (2,5-dioxo-pyrrolidin-1-yl)(phenyl)-Acetamides. International journal of molecular sciences, 22(23), . https://doi.org/10.3390/ijms222313092
Abram, Michał, et al. "Identification of New Compounds with Anticonvulsant and Antinociceptive Properties in a Group of 3-substituted (2,5-dioxo-pyrrolidin-1-yl)(phenyl)-Acetamides." International journal of molecular sciences vol. 22,23 (2021). doi: https://doi.org/10.3390/ijms222313092
Abram M, Jakubiec M, Rapacz A, Mogilski S, Latacz G, Szulczyk B, Szafarz M, Socała K, Nieoczym D, Wyska E, Wlaź P, Kamiński RM, Kamiński K. Identification of New Compounds with Anticonvulsant and Antinociceptive Properties in a Group of 3-substituted (2,5-dioxo-pyrrolidin-1-yl)(phenyl)-Acetamides. Int J Mol Sci. 2021 Dec 03;22(23). doi: 10.3390/ijms222313092. PMID: 34884898.
Copy Download .nbib Format: NLM
Showing 56557 to 808 of 808 entries